Found 91 results in Expert Content

Summary: Proactive clinical supply risk evaluation and tailored strategies to support on-time study start-up for small and mid-sized sponsors...

Summary: The Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies. Managing a clinical supply distribution strategy within APAC...

Summary: After 3 years of Brexit withdrawal negotiations, the UK is officially no longer a member of the European Union. Clinical sponsors with active and planned studies in the EU...

Summary: Overcoming complex blinding and masking challenges in clinical trials requires a balance of strategy and adaptability. When conducting clinical trials...

Summary: Formulating drugs for optimal stability and bioavailability is fundamental to the development of new pharmaceutical products. Once developed, these products must then be delivered...

Summary: Accelerating the flow of clinical supplies both into and out of China can be accomplished using a dual-supply site model. Learn how this approach leverages both...

Summary: No two studies are the same and each clinical supply project carries unique risks. Experienced supply chain managers know that certain study characteristics are often leading indicators that they can...

Summary: The traditional clinical supply model is a static, linear stock based approach that uses bulk storage to ship to depots based on anticipated demand. The supply for an entire clinical trial...

Summary: A short video on Catalent's flexible and innovative clinical supply services for phase 1-4 clinical trial sponsors. We have the deep expertise, global capabilities and...

Summary: Catalent understands there are numerous ways to approach the various facets of blinding drugs for use in a clinical trial. Employing the right blinding strategy can...